(Q58672639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Stable ethics: enrolling non-treatment-refractory volunteers in novel gene transfer trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

Jonathan Kimmelman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1904-1906

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

Defining and describing benefit appropriately in clinical trials

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Perceptions of cancer patients and their physicians involved in phase I trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Phase I cancer trials. A collusion of misunderstanding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Panel approves gene trial for "normals".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Recent developments in gene transfer: risk and ethics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Clinical gene transfer studies for hemophilia B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Reasonable risks in clinical research: a critique and a proposal for the Integrative Approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Thinking clearly about research risk: implications of the work of Benjamin Freedman.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Valuing risk: the ethical review of clinical trial safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Does Research Ethics Rest on a Mistake? The Common Good, Reasonable Risk and Social Justice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Community consultation in socially sensitive research. Lessons from clinical trials of treatments for AIDS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Harm, ethics committees and the gene therapy death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

The role of community advisory boards: involving communities in the informed consent process.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300316

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17948045%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference